Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

American Healthcare REIT (AHR) Other Non Operating Income (2019 - 2025)

American Healthcare REIT (AHR) has disclosed Other Non Operating Income for 7 consecutive years, with -$3.1 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Other Non Operating Income rose 98.11% year-over-year to -$3.1 million, compared with a TTM value of $46000.0 through Dec 2025, up 100.03%, and an annual FY2025 reading of $46000.0, up 100.03% over the prior year.
  • Other Non Operating Income was -$3.1 million for Q4 2025 at American Healthcare REIT, down from -$977000.0 in the prior quarter.
  • Across five years, Other Non Operating Income topped out at $48.8 million in Q2 2025 and bottomed at -$165.9 million in Q4 2024.
  • Average Other Non Operating Income over 5 years is -$18.5 million, with a median of -$1.3 million recorded in 2023.
  • The sharpest move saw Other Non Operating Income crashed 12679.35% in 2024, then skyrocketed 575.22% in 2025.
  • Year by year, Other Non Operating Income stood at $3.8 million in 2021, then crashed by 3670.76% to -$134.6 million in 2022, then skyrocketed by 99.04% to -$1.3 million in 2023, then plummeted by 12679.35% to -$165.9 million in 2024, then surged by 98.11% to -$3.1 million in 2025.
  • Business Quant data shows Other Non Operating Income for AHR at -$3.1 million in Q4 2025, -$977000.0 in Q3 2025, and $48.8 million in Q2 2025.